RU2008110083A - Ингибиторы протеинкиназы на основе алкоксииндолинонов - Google Patents

Ингибиторы протеинкиназы на основе алкоксииндолинонов Download PDF

Info

Publication number
RU2008110083A
RU2008110083A RU2008110083/04A RU2008110083A RU2008110083A RU 2008110083 A RU2008110083 A RU 2008110083A RU 2008110083/04 A RU2008110083/04 A RU 2008110083/04A RU 2008110083 A RU2008110083 A RU 2008110083A RU 2008110083 A RU2008110083 A RU 2008110083A
Authority
RU
Russia
Prior art keywords
compound
tautomer
salt
prodrug
represented
Prior art date
Application number
RU2008110083/04A
Other languages
English (en)
Russian (ru)
Inventor
Конгксин ЛИАНГ (US)
Конгксин ЛИАНГ
Янгбо ФЕНГ (US)
Янгбо ФЕНГ
Original Assignee
Зе Скрипс Ресеч Инститьют (Us)
Зе Скрипс Ресеч Инститьют
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зе Скрипс Ресеч Инститьют (Us), Зе Скрипс Ресеч Инститьют filed Critical Зе Скрипс Ресеч Инститьют (Us)
Publication of RU2008110083A publication Critical patent/RU2008110083A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
RU2008110083/04A 2005-09-22 2006-09-21 Ингибиторы протеинкиназы на основе алкоксииндолинонов RU2008110083A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71947405P 2005-09-22 2005-09-22
US60/719,474 2005-09-22

Publications (1)

Publication Number Publication Date
RU2008110083A true RU2008110083A (ru) 2009-10-27

Family

ID=37900093

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008110083/04A RU2008110083A (ru) 2005-09-22 2006-09-21 Ингибиторы протеинкиназы на основе алкоксииндолинонов

Country Status (10)

Country Link
US (2) US7629339B2 (enExample)
EP (1) EP1926725A4 (enExample)
JP (1) JP2009508971A (enExample)
KR (1) KR20080046701A (enExample)
CN (1) CN101282965A (enExample)
AU (1) AU2006294600A1 (enExample)
BR (1) BRPI0616378A2 (enExample)
CA (1) CA2621809A1 (enExample)
RU (1) RU2008110083A (enExample)
WO (1) WO2007038251A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629339B2 (en) * 2005-09-22 2009-12-08 The Scripps Research Institute Alkoxy indolinone based protein kinase inhibitors
US7928136B2 (en) 2006-09-11 2011-04-19 Curis, Inc. Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety
ES2565683T3 (es) * 2006-09-15 2016-04-06 Xcovery, Inc. Compuestos inhibidores de quinasa
US8969361B2 (en) 2012-04-20 2015-03-03 Annji Pharmaceutical Co., Ltd. Cyclopropanecarboxylate esters of purine analogues
RS58384B1 (sr) 2014-03-07 2019-04-30 Hoffmann La Roche Novi 6-fuzionisani heteroarildihidropirimidini za lečenje i profilaksu infekcije virusom hepatitisa b
DK3270915T3 (da) 2015-03-16 2020-06-15 Hoffmann La Roche Kombineret behandling med en TLR7-agonist og en HBV-kapsidsamlingsinhibitor
PL3512556T3 (pl) 2016-09-13 2021-12-27 F. Hoffmann-La Roche Ag Leczenie skojarzone agonistą TLR7 i inhibitorem składania kapsydu HBV
CN110016052B (zh) * 2018-01-08 2021-09-28 四川海思科制药有限公司 N-去乙基舒尼替尼的磷酰胺衍生物及其制备方法
AU2020249331A1 (en) 2019-03-25 2021-09-23 F. Hoffmann-La Roche Ag Solid forms of a compound of HBV core protein allosteric modifier

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US72934A (en) * 1867-12-31 Improvement in marking-gauge fob sswim-mgohines
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
TWI259081B (en) * 2001-10-26 2006-08-01 Sugen Inc Treatment of acute myeloid leukemia with indolinone compounds
MXPA06006050A (es) * 2003-11-26 2007-05-24 Scripps Research Inst Inhibidores de proteina quinasa a base de indolinona.
US7629339B2 (en) * 2005-09-22 2009-12-08 The Scripps Research Institute Alkoxy indolinone based protein kinase inhibitors

Also Published As

Publication number Publication date
WO2007038251A1 (en) 2007-04-05
US20090305382A1 (en) 2009-12-10
AU2006294600A1 (en) 2007-04-05
BRPI0616378A2 (pt) 2011-06-21
KR20080046701A (ko) 2008-05-27
EP1926725A1 (en) 2008-06-04
JP2009508971A (ja) 2009-03-05
CN101282965A (zh) 2008-10-08
CA2621809A1 (en) 2007-04-05
US7629339B2 (en) 2009-12-08
EP1926725A4 (en) 2010-10-06
US20070072934A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
ES2624795T3 (es) Derivados de N-(heteroaril)-1-heteroaril-1H-indol-2-carboxamidas, su preparación y su aplicación en terapéutica
AR048523A1 (es) Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
AR059184A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion en tarapeutica
MX2021009763A (es) Derivados de 3-(1-oxo-5-(piperidin-4-il)isoindolin-2-il)piperidina -2,6-diona y usos de los mismos.
AR069804A1 (es) Agonistas del receptor glucocorticoide c20- c21 sustituido
ECSP10010337A (es) Derivados de carboxamidas azabicíclicas, su preparación y su aplicación en terapéutica
RU2008110083A (ru) Ингибиторы протеинкиназы на основе алкоксииндолинонов
AR081626A1 (es) Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
RU2007103815A (ru) Производное тиенопиразола, имеющее ингибирующую фосфодиэстеразу 7(pde 7) активность
EA201170096A1 (ru) Замещенные производные пиримидона
EA200970493A1 (ru) Макроциклические ингибиторы вируса гепатита с
RU2011103454A (ru) Бициклические гетероциклы в качестве ингибиторов киназы мек
EA201070871A1 (ru) Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии
ATE556058T1 (de) 1-(2h)-isochinolonderivat
NI200900037A (es) Derivados de 2-aril-6-fenil-imidazo[1,2-alfa] piridinas, su preparación y su aplicación en terapéutica.
AR058554A1 (es) Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5.
CO6160296A2 (es) Derivados de acido benzoazepin-oxi-acetico como agonistas de receptores activados por proliferador de peroxisona delta usados para incrementar la lipoproteina de alta densidad-colesterol-colesterol reducir la lipoproteina de baja densidad-colesterol
CO6300861A2 (es) Compuestos inhibidores de dipeptidil peptidasa iv metodos de preparacion de los mismos y composiciones farmaceuticas que los contienen como agentes activos
ES2653419T3 (es) Pirazolopirimidinilamino-indazoles sustituidos
CO6220970A2 (es) Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos
RU2013147400A (ru) Способ получения производных кето-бензофурана
EA201070839A1 (ru) Новые производные ацилцианопирролидинов
AR076098A1 (es) Derivados de benzofurano
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
PH12017501655B1 (en) Morphinan derivative

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20110112